After leukemia treatments failed, Alyssa Tapley, at age 13, was told she would die. Then, doctors tried an experimental gene-edited therapy. She became the first human to try the treatment made possible by U.S. federal funding. Now 16, she’s cancer-free and planning her future. cbsn.ws/4ou0OMt

In-vivo CAR-T is the rage and it may work, but it is not clear it has the durability or long-term efficacy of ex-vivo. In general, I bet ex vivo in multiple applications will get cheaper and will win in some big verticals.

Paul Stoffels is not giving up on the cell therapy plans he had at Galapagos the former J&J CSO has started a new biotech called Armed Cell Therapeutics to buy the preclinical CAR-T platform from the Belgian biotech he had tried turning around @endpts endpoints.news/paul-stoffels…

Fascinating view into the origin and impact of a program I was the first person to turn down. So clear from this profile how important Danielle was to crafting that inaugural interview visit and the whole process. I’m happy with where I landed but it’s always fun to think what if

Ben Wilson (@BenWilsonTweets) has stage 4 cancer and 4 kids under the age of 5. I want to help him as much as possible, so I invited him on the podcast to talk about his work studying history’s greatest leaders and what it’s like getting told he’s going to die at 38. He’s a good guy, a close friend, and one of my favorite podcasters. His work has benefited millions of people all across the world. Please watch this episode and see if you can help with medicine, introductions, or donations. 0:00 What Ben has learned from making How to Take Over the World and studying history’s greatest leaders. 55:51 Living like you're dying. Ben on facing cancer.